Urinary heparan sulfates (HS) from two siblings with mucopolysaccharidosis (MPS) III-B were fractionated by chromatography with Dowex 1 and Sephadex G-50. Their Mr ranged from 1600 to 8000, and 95% of them were included in the region less than 5000. Fractions with lower Mr contained larger amounts of 0-and N-sulfates. The chemical analysis and deaminative cleavage of HS suggested that an intact HS molecule was composed of some blocks rich in G1cNAc and G1cUA and other blocks rich in G1cNS, IdUA and 0-sulfate. G1cNAc-UA-G1cNS-UAG1cNAc-UA-G1cNAc was found to be a major oligosaccharide of HS with Mr less than 1800. Trisaccharides, G1cNAc-G1cUA-aMan and G1cNAc-IdUA-aMan, were released from the nonreducing end of HS-oligosaccharides by deaminative cleavage. They carried 0-3 moles of ester sulfate. G1cNAc-IdUA-aMan was more sulfated than the other. The release of significant amounts of nonsulfated trisaccharide conform to the enzyme defect in this disease. Urinary HS obtained from another patient with MPS III were examined by the same way. Although the patient was not examined enzymatically, the structure of urinary GAG suggested a defect of a-N-acetylglucosaminidase in the patient.
Patients with MPS excrete in their urine an excessive amount of GAG with low Mr, which is a favorable material to study the structure or catabolic process of GAG. In our previous studies, it was shown that the urinary DS from patients with Hurler-Scheie syndrome (MPS I-H/S) had an IdUA residue at the nonreducing end, and only 50% of excess sulfate were bound to inner IdUA residues (Kimura et al. 1982) , whereas DS from a patient with Hunter syndrome (MPS II) had a sulfated IdUA residue at the end, and about 90% of excess sulfate remained on inner IdUA residues (Kimura et al. 1980a, b) . Thus we could confirm the enzymatic defect in these diseases by the structural studies of urinary GAG.
The present work is concerned with the structural characterization of HSoligosaccharide excreted by patients with Sanfilippo syndrome (MPS III). MPS III is characterized by excretion of excessive amounts of HS in urine and classified into four types according to the defective enzyme (Kresse et al. 1980 and references therein). To determine the type of the disease, fine structure of the excreted HS should be elucidated when the enzymatic examination cannot be conducted.
MATERIALS AND METHODS
Materials. The urine was obtained from three patients with MPS III and kept frozen until use. Two of them (TM. and EM.) are siblings with a-N-acetylglucosaminidase deficiency. Their clinical features have been reported elsewhere (Tamagawa et al. 1983 ). The other (J.M.) was unrelated and not subjected to the enzymatic examination. Some urinary HS fractions obtained from patients with MPS I-H/S and II (Kimura et al. 1980a (Kimura et al. , 1982 were also used.
Methods. The methods for the following were described previously (Kimura et al. 1980a ) ; the electrophoresic determination of urinary HS : DS : CS ratio, the isolation and fractionation of GAG by Dowex 1 and Sephadex G-50 chromatography, the identification of the fractionated GAG by electrophoresis and enzymatic digestion, the determination of Mr by gel filtration, and the chemical analysis unless stated otherwise.
Deaminative cleavage of HS was based on the low pH method of Shively and Conrad (1976) . Sample (3-50 mg) was dissolved in 0.5-2.0 ml of 0.2 M citric acid (adjusted to pH 1.5 with HCl), to which 20-80 ~ul of 1 M NaNO2 were added. After standing at room temperature for 1.5 hr, HNO2 remaining in the reaction mixture was removed by repeated evaporation with additions of methanol at 35°C. The reaction products were fractionated on a column (1.5 X 92 cm) of Sephadex G-25 (superfine) equilibrated with 0.2 M pyridineacetic acid (pH 5.3). Fractions (2.2 ml) were eluted with the pyridine-acetic acid mixture at a flow rate of 10 ml/hr.
A column (0.8 x 30 cm) of Dowex 1-X8 (Cl-, 200-400 mesh) equilibrated with 0.15 M NaCI was used to fractionate the trisaccharides separated by the gel filtration. The chromatography was developed with stepwise increased concentrations of NaCI (0.3, 0.5, 0.8 and 1.2 M, 40 ml each). Fractions (2.0 ml) were collected at a flow rate of 6 ml /hr. aMan was determined by the method of Lagunoff and Warren (1962) using, as standard, sulfated uronosyl aMan, which was prepared from HP by HNO2-degradation and purified by gel chromatography as described above.
IdUA and G1cUA were determined by the carbazole reaction modified by Kosakai and Yosizawa (1979) after released from the materials (0.5-1.0 mg as G1cUA) by the procedure of Hook et al. (1974) and separated from each other on a column (0.7 X 21 cm) of Dowex 1-X8 (formate, 200-400 mesh) using 0.3 M formic acid as an eluting solution (Fransson et al. 1968) . Fractions (0.5 ml) were collected at a flow rate of 4.0 ml/hr. Before application to the column, lactones in the reaction mixture were saponified at pH 8.0-8.2 (NH4OH) and room temperature, overnight. The excess of NH4OH was evaporated in vacuo at room temperature.
RESULTS AND DISCUSSION

Excretion patterns of GAG
As shown in Table 1 , the amounts of GAG excreted by patients, J.M., T.M. and E.M. were 3-, 15-and 36-fold, respectively, over those excreted by agemached healthy children. HS was the main component in both CPC-ppt and Dowex 1 preparations, and its ratio to other GAG was higher in Dowex 1 preparations than that in CPC-preparations.
This disagreement will be accounted for by the finding that CPC could not completely precipitate GAG with Mr less than 3000 under our experimental conditions (Kimura et al. 1980a ).
Fractionation and characterization of GAG GAG (1.5 g) obtained from a mixed urine sample of two siblings (3.2 liters from T.M. and 2.0 liters from E.M.) was fractionated into 18 fractions and GAG (0.4 g) obtained from urine (6.7 liters) excreted by J.M. into 26 fractions by the procedure using Dowex 1 and Sephadex G-50. These fractions were designated in the same manner as described previously (Kimura et al. 1980a ). The Mr of HS excreted by the siblings were distributed from 1600 to 8000, and 95% of the HS were included in the region lower than 5000. The HS excreted by J.M. showed a similar distribution pattern of Mr, but it was slightly shifted to a higher region. Deaminative cleavage of HS The oligosaccharide composition in the products of deaminative cleavage of HS will define the distribution manner of G1cNS in the original molecules. Fig.  1 shows gel filtration patterns of some representative HS fractions obtained from patients with MPS III-B, III-?, I-H/S and II. Table 2 shows the molar ratio of di-, tri-, tetra-and higher saccharide to the total. The ratio differed with difference in N-sulfate content and Mr of the fractions. No fractions examined released monosaccharide (aMan or UA) at pH 1.5 and pH 4.5 for deamination of N-sulfated and N-unsubstituted G1cN, respectively (Shively and Conrad 1976) .
HS of larger Mr (O.8AI, 1.OB1 and 1.25A1 from the patients with MPS III-B) released considerable amounts of di-, tri-and tetrasaccharides by the reaction, although "larger saccharides" were presumed to be a major degradation product on the basis of their N-sulfate contents. The result, therefore, shows that these HS contain G1cNS-rich small oligosaccharide parts in addition to G1cNAc-rich large parts as speculated above on intact HS.
Smaller Mr HS from the patients with MPS III-B and III-? released predomi- 
Structure of HS-oligosaccharides
The structure of HS-oligosaccharides with Mr less than 1800 were inferred from the N-sulfate contents and from the results of the deaminative cleavage. All the fractions examined seemed to be a mixture of the oligosaccharides shown in Table 3 . Their proportions in each fraction were calculated on the basis of the TABLE 2. Distribution of aMan-containing oligosaccharides molar ratios of aMan-containing (and -uncontaining) di-, tri-, tetra-and larger saccharides released by the deaminative cleavage (Table 3) . Although the calculation was only semiquantitative, the mixtures at the calculated ratios gave N-sulfate contents (Table 3 ) comparable with the actual values ( Table 2 ). The results showed that oligosaccharide-a (Table 3 ) was one of the major HS with Mr less than 1800 in the urine from the patients with MPS III-B and III-?.
Identification of trisaccharides derived from the nonreducing end
The Dowex 1 chromatography separated the trisaccharides derived from the nonreducing end into non-, mono-, di-and trisulfated species (Fig. 2, Table 4 ). Two other species of trisaccharide and contaminating di-and tetrasaccharides were also separated by the chromatography.
The latter two trisaccharides (Peaks 2 and 5) would be derived from HS having the reducing UA end.
The chemical analysis of the trisaccharides from the nonreducing end indicated that the trisaccharides with a larger amount of sulfate had higher IdUA/G1cUA ratios ; the trisulfated trisaccharide contained only IdUA as UA and the nonsulfated trisaccharide showed the ratio of 0.13 (Table 4 ). The result is in accordance with the recent findings on biosynthesis of HP (Jacobsson and Lindahl 1980) and HS (Riesenfeld et al. 1982 ) that the sulfation of IdUA is coupled to the epimerization of G1cUA to IdUA and that the C-6 sulfation of G1cN occurs readily in the presence of adjacent sulfated IdUA. Two sugar sequences, G1cNAc-G1cUA-G1cNS-and G1cNAc-IdUA-G1cNS-, were found as nonreducing terminal trisaccharide. The former is common in HS (Linker 1979 ), but the latter has been found in neither HS nor HP. One possible reason appears to be that G1cUA C-5 epimerase cannot convert G1cUA substituted (at C-4) with G1cNAc to IdUA in the biosynthetic process of HS (Riesenfeld et al. Chemical components and proposed structures from the trisaccharide fractions of oligosaccharidesobtained 1982) as well as of HP (Jacobsson and Lindahl 1980) . On the other hand in the catabolic process, G1cNS residues in HS are supposed to be altered to G1cNAc at the nonreducing end by succesive N-desulfation and N-acetylation reactions (Klein et al. 1978 ). Therefore, GIcNAc-IdUA-G1cNS-may arise from a sequence, -G1cNS-IdUA-G1cNS-, in a HS-polysaccharide chain when the sequence appears at the nonreducing end in the catabolic process.
Distribution of trisaccharides with different amounts of sulfate Table 5 shows the distribution of non-, mono-, di-and trisulfated trisaccharides derived from the nonreducing end of HS in various species. The proportion of disulfated trisaccharide increased with increase in sulfate content of the original HS, and that of nonsulfated trisaccharide changed inversely. It is somewhat surprising to have found a large amount of disulfated trisaccharide and even trisulfated trisaccharide. However, it should be noted that the present data were obtained fairly highly sulfated species of HS.
HS from J.M. (MPS III-?) was similar to HS from the patients with MPS III-B in distribution pattern of these trisaccharides. The release of significant amounts of nonsulfated trisaccharide from his HS suggests that a-N-acetylglucosaminidase is defective in this patient as in MPS III-B.
The binding sites of ester sulfate on the trisaccharides were not studied in this work. The C-6 of G1cNAc and G1eNS, and C-2 of IdUA are well-known sulfation sites in HS (Sanderson et al. 1983 ; Delaney and Conrad 1983) and HP (Kosakai and Yosizawa 1981) . Since the G1cNAc residue of the trisaccharides is, however, presumed to have no sulfate group, one more site for sulfation should be found on TABLE 5 . Distribution of GIcNAc-UA-aMan with different amonts of sulfate such trisaccharides as G1cNAc-G1cUA-aMan (diSO4) and G1cNAc-IdUA-aMan (triSO4). Recently Lindahl et al. (1980) reported the presence of a 2-N-3, 6-0-trisulfated G1cN residue in the antithrombin-binding sequence of HP. If such is the case with these trisaccharides, all sulfate groups could settle down. The location of sulfate groups on the trisaccharides remains unsolved.
